APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Genetic Defect Screening Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pet Genetic Defect Screening Platform Market Analysis and Forecast 2026-2032

16 April 2026197 pages

Choose your research edition.

Industry ResearchPet Genetic Defect Screening Platform Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Genetic Defect Screening Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pet Genetic Defect Screening Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Genetic Defect Screening Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pet Genetic Defect Screening Platform Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Genetic Defect Screening Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pet Genetic Defect Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pet Genetic Defect Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pet Genetic Defect Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pet Genetic Defect Screening Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pet Genetic Defect Screening Platform include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pet Genetic Defect Screening Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pet Genetic Defect Screening Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Genetic Defect Screening Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pet Genetic Defect Screening Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Genetic Defect Screening Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Genetic Defect Screening Platform revenue, projected growth trends, production technology, application and end-user industry.

Pet Genetic Defect Screening Platform Segment by Company

Wisdom Panel

Embark Veterinary

Basepaws

Orivet Genetic Pet Care

Paw Print Genetics

Animal Genetics

VetGen

Antagene

Laboklin

UC Davis

OptiGen

VHLGenetics

Sinogene

PawKnows

Circle Dog

BGI Genomics

GENEWIZ

Pet Genetic Defect Screening Platform Segment by Type

Single Disease Gene Screening Platform

Whole Genome Multi-Disease Comprehensive Screening Platform

Pet Genetic Defect Screening Platform Segment by Application

Medical Institutions

Insurance Companies

Pet Breeding Companies

Others

Pet Genetic Defect Screening Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Defect Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Defect Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Defect Screening Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pet Genetic Defect Screening Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pet Genetic Defect Screening Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Genetic Defect Screening Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Disease Gene Screening Platform Major Player Table 3. Whole Genome Multi-Disease Comprehensive Screening Platform Major Player Table 4. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Institutions Major Player Table 6. Insurance Companies Major Player Table 7. Pet Breeding Companies Major Player Table 8. Others Major Player Table 9. Pet Genetic Defect Screening Platform Industry Trends Table 10. Pet Genetic Defect Screening Platform Industry Drivers Table 11. Pet Genetic Defect Screening Platform Industry Opportunities and Challenges Table 12. Pet Genetic Defect Screening Platform Industry Restraints Table 13. Global Pet Genetic Defect Screening Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pet Genetic Defect Screening Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pet Genetic Defect Screening Platform Market Share by Region (2021-2026) Table 16. Global Pet Genetic Defect Screening Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pet Genetic Defect Screening Platform Market Share by Region (2027-2032) Table 18. Global Pet Genetic Defect Screening Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pet Genetic Defect Screening Platform Revenue Market Share by Players (2021-2026) Table 20. Global Pet Genetic Defect Screening Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pet Genetic Defect Screening Platform Key Players Headquarters & Area Served Table 22. Global Pet Genetic Defect Screening Platform Players, Product Type & Application Table 23. Global Pet Genetic Defect Screening Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pet Genetic Defect Screening Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pet Genetic Defect Screening Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2021-2026) Table 30. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2027-2032) Table 31. Global Pet Genetic Defect Screening Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021-2026) Table 35. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2027-2032) Table 36. Wisdom Panel Company Information Table 37. Wisdom Panel Business Overview Table 38. Wisdom Panel Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio Table 40. Wisdom Panel Recent Development Table 41. Embark Veterinary Company Information Table 42. Embark Veterinary Business Overview Table 43. Embark Veterinary Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio Table 45. Embark Veterinary Recent Development Table 46. Basepaws Company Information Table 47. Basepaws Business Overview Table 48. Basepaws Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Basepaws Pet Genetic Defect Screening Platform Product Portfolio Table 50. Basepaws Recent Development Table 51. Orivet Genetic Pet Care Company Information Table 52. Orivet Genetic Pet Care Business Overview Table 53. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio Table 55. Orivet Genetic Pet Care Recent Development Table 56. Paw Print Genetics Company Information Table 57. Paw Print Genetics Business Overview Table 58. Paw Print Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 60. Paw Print Genetics Recent Development Table 61. Animal Genetics Company Information Table 62. Animal Genetics Business Overview Table 63. Animal Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 65. Animal Genetics Recent Development Table 66. VetGen Company Information Table 67. VetGen Business Overview Table 68. VetGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. VetGen Pet Genetic Defect Screening Platform Product Portfolio Table 70. VetGen Recent Development Table 71. Antagene Company Information Table 72. Antagene Business Overview Table 73. Antagene Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Antagene Pet Genetic Defect Screening Platform Product Portfolio Table 75. Antagene Recent Development Table 76. Laboklin Company Information Table 77. Laboklin Business Overview Table 78. Laboklin Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Laboklin Pet Genetic Defect Screening Platform Product Portfolio Table 80. Laboklin Recent Development Table 81. UC Davis Company Information Table 82. UC Davis Business Overview Table 83. UC Davis Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. UC Davis Pet Genetic Defect Screening Platform Product Portfolio Table 85. UC Davis Recent Development Table 86. OptiGen Company Information Table 87. OptiGen Business Overview Table 88. OptiGen Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. OptiGen Pet Genetic Defect Screening Platform Product Portfolio Table 90. OptiGen Recent Development Table 91. VHLGenetics Company Information Table 92. VHLGenetics Business Overview Table 93. VHLGenetics Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio Table 95. VHLGenetics Recent Development Table 96. Sinogene Company Information Table 97. Sinogene Business Overview Table 98. Sinogene Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Sinogene Pet Genetic Defect Screening Platform Product Portfolio Table 100. Sinogene Recent Development Table 101. PawKnows Company Information Table 102. PawKnows Business Overview Table 103. PawKnows Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. PawKnows Pet Genetic Defect Screening Platform Product Portfolio Table 105. PawKnows Recent Development Table 106. Circle Dog Company Information Table 107. Circle Dog Business Overview Table 108. Circle Dog Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Circle Dog Pet Genetic Defect Screening Platform Product Portfolio Table 110. Circle Dog Recent Development Table 111. BGI Genomics Company Information Table 112. BGI Genomics Business Overview Table 113. BGI Genomics Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio Table 115. BGI Genomics Recent Development Table 116. GENEWIZ Company Information Table 117. GENEWIZ Business Overview Table 118. GENEWIZ Pet Genetic Defect Screening Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio Table 120. GENEWIZ Recent Development Table 121. North America Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Pet Genetic Defect Screening Platform Revenue by Country (2021-2026) & (US$ Million) Table 127. North America Pet Genetic Defect Screening Platform Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Pet Genetic Defect Screening Platform Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe Pet Genetic Defect Screening Platform Revenue by Country (US$ Million) & (2027-2032) Table 135. China Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 136. China Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 137. China Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 138. China Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Pet Genetic Defect Screening Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Pet Genetic Defect Screening Platform Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia Pet Genetic Defect Screening Platform Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA Pet Genetic Defect Screening Platform Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Pet Genetic Defect Screening Platform Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Pet Genetic Defect Screening Platform Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA Pet Genetic Defect Screening Platform Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA Pet Genetic Defect Screening Platform Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA Pet Genetic Defect Screening Platform Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Pet Genetic Defect Screening Platform Image Figure 2. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Genetic Defect Screening Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Disease Gene Screening Platform Image Figure 5. Whole Genome Multi-Disease Comprehensive Screening Platform Image Figure 6. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pet Genetic Defect Screening Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Institutions Image Figure 9. Insurance Companies Image Figure 10. Pet Breeding Companies Image Figure 11. Others Image Figure 12. Global Pet Genetic Defect Screening Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global Pet Genetic Defect Screening Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pet Genetic Defect Screening Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pet Genetic Defect Screening Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pet Genetic Defect Screening Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pet Genetic Defect Screening Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2021-2032) Figure 20. Global Pet Genetic Defect Screening Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021-2032) Figure 23. North America Pet Genetic Defect Screening Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032) Figure 25. North America Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032) Figure 26. North America Pet Genetic Defect Screening Platform Revenue Share by Country (2021-2032) Figure 27. United States Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pet Genetic Defect Screening Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032) Figure 32. Europe Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032) Figure 33. Europe Pet Genetic Defect Screening Platform Revenue Share by Country (2021-2032) Figure 34. Germany Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pet Genetic Defect Screening Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032) Figure 44. China Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032) Figure 45. Asia Pet Genetic Defect Screening Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032) Figure 47. Asia Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032) Figure 48. Asia Pet Genetic Defect Screening Platform Revenue Share by Region (2021-2032) Figure 49. Japan Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pet Genetic Defect Screening Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA Pet Genetic Defect Screening Platform Revenue Share by Country (2021-2032) Figure 59. Brazil Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pet Genetic Defect Screening Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Disease Gene Screening Platform
  • Whole Genome Multi-Disease Comprehensive Screening Platform
Applications
  • Medical Institutions
  • Insurance Companies
  • Pet Breeding Companies
  • Others
Companies covered
  • Wisdom Panel
  • Embark Veterinary
  • Basepaws
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • Animal Genetics
  • VetGen
  • Antagene
  • Laboklin
  • UC Davis
  • OptiGen
  • VHLGenetics
  • Sinogene
  • PawKnows
  • Circle Dog
  • BGI Genomics
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pet Genetic Defect Screening Platform Market by Type
  3. 1.2.1 Global Pet Genetic Defect Screening Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Disease Gene Screening Platform
  5. 1.2.3 Whole Genome Multi-Disease Comprehensive Screening Platform
  6. 1.3 Pet Genetic Defect Screening Platform Market by Application
  7. 1.3.1 Global Pet Genetic Defect Screening Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Institutions
  9. 1.3.3 Insurance Companies
  10. 1.3.4 Pet Breeding Companies
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pet Genetic Defect Screening Platform Market Dynamics
  1. 2.1 Pet Genetic Defect Screening Platform Industry Trends
  2. 2.2 Pet Genetic Defect Screening Platform Industry Drivers
  3. 2.3 Pet Genetic Defect Screening Platform Industry Opportunities and Challenges
  4. 2.4 Pet Genetic Defect Screening Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pet Genetic Defect Screening Platform Market Perspective (2021-2032)
  2. 3.2 Global Pet Genetic Defect Screening Platform Growth Trends by Region
  3. 3.2.1 Global Pet Genetic Defect Screening Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pet Genetic Defect Screening Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Pet Genetic Defect Screening Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pet Genetic Defect Screening Platform Revenue by Players
  2. 4.1.1 Global Pet Genetic Defect Screening Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Pet Genetic Defect Screening Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pet Genetic Defect Screening Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pet Genetic Defect Screening Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pet Genetic Defect Screening Platform Key Players Headquarters & Area Served
  7. 4.4 Global Pet Genetic Defect Screening Platform Players, Product Type & Application
  8. 4.5 Global Pet Genetic Defect Screening Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pet Genetic Defect Screening Platform Market CR5 and HHI
  11. 4.6.3 2025 Pet Genetic Defect Screening Platform Tier 1, Tier 2, and Tier 3
5 Pet Genetic Defect Screening Platform Market Size by Type
  1. 5.1 Global Pet Genetic Defect Screening Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 5.3 Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2021-2032)
6 Pet Genetic Defect Screening Platform Market Size by Application
  1. 6.1 Global Pet Genetic Defect Screening Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  3. 6.3 Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Wisdom Panel
  2. 7.1.1 Wisdom Panel Company Information
  3. 7.1.2 Wisdom Panel Business Overview
  4. 7.1.3 Wisdom Panel Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio
  6. 7.1.5 Wisdom Panel Recent Developments
  7. 7.2 Embark Veterinary
  8. 7.2.1 Embark Veterinary Company Information
  9. 7.2.2 Embark Veterinary Business Overview
  10. 7.2.3 Embark Veterinary Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio
  12. 7.2.5 Embark Veterinary Recent Developments
  13. 7.3 Basepaws
  14. 7.3.1 Basepaws Company Information
  15. 7.3.2 Basepaws Business Overview
  16. 7.3.3 Basepaws Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Basepaws Pet Genetic Defect Screening Platform Product Portfolio
  18. 7.3.5 Basepaws Recent Developments
  19. 7.4 Orivet Genetic Pet Care
  20. 7.4.1 Orivet Genetic Pet Care Company Information
  21. 7.4.2 Orivet Genetic Pet Care Business Overview
  22. 7.4.3 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio
  24. 7.4.5 Orivet Genetic Pet Care Recent Developments
  25. 7.5 Paw Print Genetics
  26. 7.5.1 Paw Print Genetics Company Information
  27. 7.5.2 Paw Print Genetics Business Overview
  28. 7.5.3 Paw Print Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio
  30. 7.5.5 Paw Print Genetics Recent Developments
  31. 7.6 Animal Genetics
  32. 7.6.1 Animal Genetics Company Information
  33. 7.6.2 Animal Genetics Business Overview
  34. 7.6.3 Animal Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio
  36. 7.6.5 Animal Genetics Recent Developments
  37. 7.7 VetGen
  38. 7.7.1 VetGen Company Information
  39. 7.7.2 VetGen Business Overview
  40. 7.7.3 VetGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 VetGen Pet Genetic Defect Screening Platform Product Portfolio
  42. 7.7.5 VetGen Recent Developments
  43. 7.8 Antagene
  44. 7.8.1 Antagene Company Information
  45. 7.8.2 Antagene Business Overview
  46. 7.8.3 Antagene Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Antagene Pet Genetic Defect Screening Platform Product Portfolio
  48. 7.8.5 Antagene Recent Developments
  49. 7.9 Laboklin
  50. 7.9.1 Laboklin Company Information
  51. 7.9.2 Laboklin Business Overview
  52. 7.9.3 Laboklin Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Laboklin Pet Genetic Defect Screening Platform Product Portfolio
  54. 7.9.5 Laboklin Recent Developments
  55. 7.10 UC Davis
  56. 7.10.1 UC Davis Company Information
  57. 7.10.2 UC Davis Business Overview
  58. 7.10.3 UC Davis Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 UC Davis Pet Genetic Defect Screening Platform Product Portfolio
  60. 7.10.5 UC Davis Recent Developments
  61. 7.11 OptiGen
  62. 7.11.1 OptiGen Company Information
  63. 7.11.2 OptiGen Business Overview
  64. 7.11.3 OptiGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 OptiGen Pet Genetic Defect Screening Platform Product Portfolio
  66. 7.11.5 OptiGen Recent Developments
  67. 7.12 VHLGenetics
  68. 7.12.1 VHLGenetics Company Information
  69. 7.12.2 VHLGenetics Business Overview
  70. 7.12.3 VHLGenetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio
  72. 7.12.5 VHLGenetics Recent Developments
  73. 7.13 Sinogene
  74. 7.13.1 Sinogene Company Information
  75. 7.13.2 Sinogene Business Overview
  76. 7.13.3 Sinogene Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sinogene Pet Genetic Defect Screening Platform Product Portfolio
  78. 7.13.5 Sinogene Recent Developments
  79. 7.14 PawKnows
  80. 7.14.1 PawKnows Company Information
  81. 7.14.2 PawKnows Business Overview
  82. 7.14.3 PawKnows Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 PawKnows Pet Genetic Defect Screening Platform Product Portfolio
  84. 7.14.5 PawKnows Recent Developments
  85. 7.15 Circle Dog
  86. 7.15.1 Circle Dog Company Information
  87. 7.15.2 Circle Dog Business Overview
  88. 7.15.3 Circle Dog Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Circle Dog Pet Genetic Defect Screening Platform Product Portfolio
  90. 7.15.5 Circle Dog Recent Developments
  91. 7.16 BGI Genomics
  92. 7.16.1 BGI Genomics Company Information
  93. 7.16.2 BGI Genomics Business Overview
  94. 7.16.3 BGI Genomics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio
  96. 7.16.5 BGI Genomics Recent Developments
  97. 7.17 GENEWIZ
  98. 7.17.1 GENEWIZ Company Information
  99. 7.17.2 GENEWIZ Business Overview
  100. 7.17.3 GENEWIZ Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio
  102. 7.17.5 GENEWIZ Recent Developments
8 North America
  1. 8.1 North America Pet Genetic Defect Screening Platform Revenue (2021-2032)
  2. 8.2 North America Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Pet Genetic Defect Screening Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Pet Genetic Defect Screening Platform Revenue by Type (2027-2032)
  5. 8.3 North America Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Pet Genetic Defect Screening Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Pet Genetic Defect Screening Platform Revenue by Application (2027-2032)
  9. 8.5 North America Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Pet Genetic Defect Screening Platform Revenue by Country
  11. 8.6.1 North America Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pet Genetic Defect Screening Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Pet Genetic Defect Screening Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pet Genetic Defect Screening Platform Revenue (2021-2032)
  2. 9.2 Europe Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pet Genetic Defect Screening Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pet Genetic Defect Screening Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pet Genetic Defect Screening Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pet Genetic Defect Screening Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pet Genetic Defect Screening Platform Revenue by Country
  11. 9.6.1 Europe Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pet Genetic Defect Screening Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pet Genetic Defect Screening Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pet Genetic Defect Screening Platform Revenue (2021-2032)
  2. 10.2 China Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Pet Genetic Defect Screening Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Pet Genetic Defect Screening Platform Revenue by Type (2027-2032)
  5. 10.3 China Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Pet Genetic Defect Screening Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Pet Genetic Defect Screening Platform Revenue by Application (2027-2032)
  9. 10.5 China Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pet Genetic Defect Screening Platform Revenue (2021-2032)
  2. 11.2 Asia Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pet Genetic Defect Screening Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pet Genetic Defect Screening Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pet Genetic Defect Screening Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pet Genetic Defect Screening Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pet Genetic Defect Screening Platform Revenue by Country
  11. 11.6.1 Asia Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pet Genetic Defect Screening Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pet Genetic Defect Screening Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pet Genetic Defect Screening Platform Revenue (2021-2032)
  2. 12.2 SAMEA Pet Genetic Defect Screening Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pet Genetic Defect Screening Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pet Genetic Defect Screening Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pet Genetic Defect Screening Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pet Genetic Defect Screening Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pet Genetic Defect Screening Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pet Genetic Defect Screening Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pet Genetic Defect Screening Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pet Genetic Defect Screening Platform Revenue by Country
  11. 12.6.1 SAMEA Pet Genetic Defect Screening Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pet Genetic Defect Screening Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pet Genetic Defect Screening Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst